A new study examined whether urinary biomarkers could predict future kidney complications in individuals with lupus nephritis ...

As overweight and obesity levels rise in populations the world over, they pose much more than cosmetic and mobility challenges to people. Body fat, especially v ...

A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that ...

Researchers have found in a new study that lean adolescents with polycystic ovary syndrome (PCOS) exhibit significantly greater adipose tissue dysfunction and insulin resistance compared with ...

Jay N. Yepuri, MD, MS, FACG, is a board-certified gastroenterologist and member of the Digestive Health Associates of Texas Board of Directors and Executive Committee. A liver function test checks how ...

A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that blocks activin signaling pathways, results in greater weight loss while also ...

A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that ...

This article examines how exercise-induced exerkines prevent disease, as well as promote metabolic, cardiovascular, immune, ...

CEO Jasbir Seehra outlined the company’s development priorities and partnership plans during a presentation at Oppenheimer’s 36th Annual Healthcare Life Sciences conference, highlighting plans to init ...

Girls with central precocious puberty (CPP) and premature thelarche exhibit distinct DXA-based body composition and bone density patterns.

Oppenheimer 36th Annual Healthcare Life Sciences Conference February 26, 2026 9:20 AM ESTCompany ParticipantsDavid Happel ...